Previous 10 | Next 10 |
That which is common to the greatest number has the least care bestowed upon it, everybody is more inclined to neglect the duty which he expects another to fulfill.” - Aristotle, Politics Markets stabilized somewhat last week after a month of Wuhan coronavirus or Covid-19-trigge...
Exelixis (NASDAQ: EXEL ) announces that the Japanese Ministry of Health, Labor and Welfare has approved collaboration partner and licensee Takeda Pharmaceutical Company's (NYSE: TAK ) application to manufacture and market Cabometyx (cabozantinib) for patients with curatively unresectable o...
Growing your wealth takes time and patience -- both of which have been put to the test in a big way over the past month. The spread of the coronavirus disease (COVID-19) across the globe has wreaked havoc on equities, commodities, and bonds, leaving little refuge for investors. The uncertainty ...
Exelixis, Inc. (NASDAQ: EXEL) today announced that Takeda Pharmaceutical Company Limited (Takeda), its partner responsible for the clinical development and commercialization of CABOMETYX ® (cabozantinib) in Japan, received approval from the Japanese Ministry of Health, Labor and Welfa...
You might think of biotech stocks as risky propositions. And some of them are. But not all of them. Actually, with the COVID-19 pandemic raging, biotechs that are consistently profitable and that sell drugs that patients absolutely must have could be viewed as relatively safe compared to many o...
A very quiet and tasteful way to be famous is to have a famous relative. Then you can not only be nothing, you can do nothing too ."- P. J. O'Rourke It was a wild week for investors as the markets went through their most volatile week of trading since the 2008 financial crisis. Sports lea...
Biotech and biopharma stocks regained their footing last Friday after a historically brutal week. For instance, shares of AnaptysBio (NASDAQ: ANAB) closed up by 12.5% last Friday; bluebird bio (NASDAQ: BLUE) stock posted a modest 2.17% gain after dipping by as much ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Shares of some healthcare companies couldn't escape the wrath of COVID-19, the disease caused by the novel coronavirus. NuVasive (NASDAQ: NUVA) closed down 13% on Thursday, while Exelixis (NASDAQ: EXEL) slumped 12% and Natus Medical (NASDAQ: NTUS) dropped a whopping 17%. The broade...
Exelixis, Inc. (EXEL) Barclays Global Healthcare Conference 2020 March 10, 2020 03:50 PM ET Company Participants Mike Morrissey - Chief Executive Officer Conference Call Participants Peter Lawson - Barclays Presentation Peter Lawson Good afternoon. Welcome to Barclays...
News, Short Squeeze, Breakout and More Instantly...
– Conference Call and Webcast to Follow at 5:00 p.m. ET / 2:00 p.m. PT – Exelixis, Inc. (Nasdaq: EXEL) announced today that its second quarter 2024 financial results will be released on Tuesday, August 6, 2024 after the markets close. At 5:00 p.m. ET / 2:00 p.m. PT, Ex...
2024-07-11 08:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...